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Summary
The clathrin-associated protein, Huntingtin Interacting Protein 1 (HIP1), is overexpressed in multiple human epithelial
tumors. Here, we report that HIP1 is a novel oncoprotein that transforms cells. HIP1-transformed cells, in contrast to
RasV12-transformed cells, have dysregulation of multiple receptors involved in clathrin trafficking. Examples include
upregulation of the epidermal growth factor receptor (EGFR) and the transferrin receptor. Furthermore, accumulation of
transferrin and EGF in the HIP1-transformed cells was increased, and breast tumors that had EGFR expressed also had
HIP1 upregulated. Thus, HIP1 overexpression promotes tumor formation and is associated with a general alteration in
receptor trafficking. HIP1 is the first endocytic protein to be directly implicated in tumor formation.
Introduction and cancer in principle, none of these proteins have yet been
found to have oncogenic properties in vivo.
The Huntingtin Interacting Protein 1 (HIP1) has been shownThe importance of altered epidermal growth factor receptor
(EGFR) signaling in the generation of cancer is well documented to be a cofactor in clathrin-mediated endocytosis (Legendre-
Guillemin et al., 2002; Metzler et al., 2001; Mishra et al., 2001; Rao(Kim et al., 2001). ErbB family members such as EGFR (also
known as HER or ErbB1) and ErbB2 (also known as HER2) et al., 2001; Waelter et al., 2001). HIP1 specifically associates
with and colocalizes with clathrin and the adaptor protein AP-2.are overexpressed in multiple spontaneously occurring human
cancers. Moreover, overexpression of either EGFR (Di Fiore et In addition, a phosphatidylinositol lipid binding epsin N-terminal
homology (ENTH) domain is present at the N terminus of HIP1.al., 1987a) or erbB2 (Di Fiore et al., 1987b) transforms NIH/3T3
fibroblasts. In addition, downstream signaling targets of the To date, this domain has only been found in proteins that partici-
pate in clathrin-mediated trafficking. However, the specific func-EGFR, including Ras and Raf, have been found to have activat-
ing mutations in a variety of human cancers (Bos, 1989; Davies tion of HIP1 in endocytosis has not yet been delineated.
Recently, we demonstrated that expression of the HIP1 pro-et al., 2002). The net effect of these changes is to lead to
inappropriate activation of mitogenic signaling pathways, in- tein is elevated in multiple primary human epithelial cancers.
Increasing HIP1 expression is correlated with increasing aggres-cluding the extracellular signal-regulated kinase (ERK) pathway
with resultant cellular transformation. siveness of prostate cancer, and HIP1 expression is an indepen-
dent predictor of relapse in patients with prostate cancer (RaoOne mechanism whereby cells regulate intracellular signal-
ing is via clathrin-mediated growth factor receptor trafficking. et al., 2002). In addition, expression of HIP1 in prostate tumors
from TRAMP mice was higher by at least an order of magnitudeBy this process, cellular proteins that regulate endocytosis also
modulate the signal transduction pathways that originate from than normal mouse prostate tissue. These results suggested
the possibility that HIP1 overexpression may promote the trans-growth factor receptors (Di Fiore and De Camilli, 2001; Vieira
et al., 1996). Although dysregulation of proteins involved in re- formation of normal cells into cancer cells. Here, we demon-
strate that HIP1 transforms NIH/3T3 fibroblasts and upregulatesceptor trafficking may lead to abnormal intracellular signaling
S I G N I F I C A N C E
The upregulation of growth factor receptors, such as those for epidermal growth factor, has been implicated as a mechanism of
transformation in multiple human cancers. In addition to mutations, such as gene amplification, leading to elevated levels of EGFR,
alterations in receptor trafficking have been shown to alter receptor levels and intracellular signal transduction, and hypothesized
to lead to oncogenesis. Here, oncogenic transformation is shown as a direct result of the overexpression of Huntingtin Interacting
Protein 1 (HIP1), a protein that is involved in clathrin-mediated trafficking. Furthermore, overexpression of HIP1 led to changes in the
total levels of receptors and to altered trafficking of EGF and transferrin. These results implicate receptor-mediated trafficking as a
mechanism whereby oncogenic transformation may occur or be sustained by decreasing the dependence of transformed cells on
growth factors.
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multiple receptors involved in trafficking, including the well-
studied EGFR. To begin to study the mechanism of this transfor-
mation, the effects of the EGFR upregulation were tested in
detail to provide an example for how upregulation of growth
factor receptors via HIP1 overexpression could induce and/or
maintain the transformed phenotype. In addition, we report that
EGFR expression in primary breast tumors coincides with HIP1
overexpression.
Results
As a next step in our studies of HIP1 and its role in tumorigenesis,
we tested if HIP1 had oncogenic properties. We established
NIH/3T3 cell lines that stably overexpressed HIP1 under the
control of the CMV promoter. Every hygromycin-resistant clone
isolated demonstrated overexpression of HIP1, suggesting that
HIP1 overexpressing cells had a selective advantage over cells
that did not overexpress HIP1. In a parallel experiment, we
infected NIH/3T3 cells with retrovirus expressing HIP1 under
Figure 1. Stable overexpression of wild-type HIP1 but not HIP1/E was foundthe control of the LTR promoter and isolated G418-resistant
in all selected clonesclones, which were, again, all overexpressing HIP1. On the other
A: Western blot analysis of cell lines with overexpression of HIP1 under thehand, infection with a dominant interfering proapoptotic HIP1
control of the LTR promoter. MSCV-neo/HIP1 was constructed by subcloningmutant, designated HIP1/E (Rao et al., 2002), did not produce
the full-length HIP1 cDNA from pcDNA3/HIP1 into the MSCV-neo vector.
any clones expressing HIP1/E, except for one clone with ex- MSCV-neo/HIP1/E was constructed by subcloning a fragment of HIP1 lack-
tremely low levels of expression (Figure 1). ing the ENTH domain from the pcDNA3HIP1/E into MSCV-neo (Rao et al.,
2002). These constructs have HIP1 under the control of the LTR promoter.For the purposes of our analyses, we studied cell lines with
NIH/3T3 cells were infected with retroviral supernatants obtained from trans-moderate overexpression of HIP1 (designated 3T3/HIP1mod) and
fection of the MSCV-neo constructs into 293T cells as previously describedhigh overexpression of HIP1 (designated 3T3/HIP1hi). In addi-
(Saint-Dic et al., 2001). Following transfection, cells were selected in G418
tion, three independent clones derived from transfection with (400 g/ml) for 2 weeks, and individual clones were isolated and subse-
vector alone (designated 3T3/Ctrl) and three clones that ex- quently expanded. Extracts prepared from these clones were loaded onto
gels as follows: Lanes 1–7, clones from transfection with MSCV-HIP1; lanespressed high levels of oncogenic RasV12 (designated 3T3/
8–17, clones from transfection with MSCV-neo/HIP1/E. Note that in lane 8,Ha-RasV12) were selected as negative and positive controls,
there is a low-intensity band smaller than full-length HIP1, which crossreacts
respectively. The overexpressed human HIP1 protein was with both the anti-HIP1 monoclonal antibodies and was most likely the HIP1/
readily distinguished from endogenous mouse HIP1 using the E protein product.
B: Comparison of HIP1 expression levels in cell lines generated using thehuman HIP1-specific monoclonal antibody, HIP1/4B10. The lev-
MSCV-neo/HIP1 (LTR-HIP1) construct and the pTRE2-hyg/HIP1 constructels of total HIP1 were compared using a BioRad Fluor S max
(CMV-HIP1). Gels were loaded as follows: Lanes 1–7, LTR-HIP1-expressingcamera and the monoclonal antibody, HIP1/1B11, which recog-
cells as in A; lanes 8–9 were loaded with 3T3/HIP1hi; lane 10 was loaded with
nizes both human and mouse HIP1 (Figure 2A, lanes 1–3 versus 3T3/HIP1mod.
lanes 4–9). 3T3/HIP1hi cell lines expressed 100- to 200-fold more
HIP1 (while 3T3/HIP1mod expressed 5–50 fold more HIP1 than
endogenous murine HIP1) as compared to vector transfected
3T3 cells that only expressed endogenous murine HIP1 (Fig- determine if there were abnormalities in the cell cycle status of
ure 2B). cell lines overexpressing HIP1. When assayed by propidium
After establishing these cell lines, the effect of HIP1 on iodide staining and FACS analysis, a larger proportion of the
cellular proliferation rates was tested under various growth con- 3T3/HIP1hi cells were found to be in the S phase of the cell
ditions. All cell lines expressing HIP1 at moderate and high cycle (44.9 10.2%), compared to control cell lines (19.7% 
levels had higher growth rates and grew to greater densities as 2.3%), when grown to 90% confluence under normal growth
compared to control cell lines under standard growth conditions conditions (Figure 3A). As expected, similar results were seen
(Figure 2C). As expected, cell lines with overexpression of onco- with 3T3/Ha-RasV12 cells (data not shown). When the experi-
genic Ras also grew faster and to higher saturation densities ment was repeated with cells grown for 48 hr in medium with
(Figure 2C). Surprisingly, 3T3/HIP1hi cells were able to grow in 0.1% FBS, 3T3/HIP1hi cell lines still had a significantly higher
medium supplemented with only 0.1% fetal bovine serum (FBS), proportion of cells in the S phase of the cell cycle (27  2.8%
whereas 3T3/Ctrl, 3T3/HIP1mod, and 3T3/Ha-RasV12 cell lines for 3T3/HIP1hi versus 11.2  2.6% for 3T3/Ctrl), indicating in-
did not significantly proliferate under these conditions (Figure creased progression through the cell cycle (Figure 3B). These
2D). Moreover, 3T3/HIP1hi cell lines were able to grow to a higher data, together with the ability to grow in 0.1% FBS, indicate
density by 8 days than 3T3/Ctrl cell lines under both normal that drastic reductions in the amounts of growth factors in the
and low-serum conditions (Figure 2E). medium had a minimal effect on the ability of 3T3/HIP1hi cells
Exposure of NIH/3T3 cells to medium containing 0.1% FBS to progress through the cell cycle. In the complete absence of
for 48 hr is sufficient to cause exit from the cell cycle and arrest serum, HIP1-overexpressing cells survived but did not prolifer-
in G0 (Jones and Kazlauskas, 2001). Given the ability of 3T3/ ate, whereas control cells did not survive (data not shown). This
suggests that HIP1 overexpression increased the sensitivity ofHIP1hi cells to grow in medium with 0.1% FBS, we assayed to
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Figure 2. HIP1 overexpression leads to altered
growth of NIH/3T3 cells
A: Western blot analysis of NIH/3T3 cell lines used
in this study. Cell lines were generated by trans-
fection of constructs as described (Saint-Dic et
al., 2001). Gels were loaded as follows: Lane 1–3,
clones 3T3/4.1B, 3T3/4.2.B, and 3T3/4.3.E (3T3/
ctrl); Lanes 4–5, clones 3T3/5.2.A and 3T3/5.3.E
(3T3/HIP1mod); Lanes 6–9, clones 3T3/5.1.E, 3T3/
5.2.D, 3T3/5.2.C, and 3T3/5.3.F (3T3/HIP1hi); Lanes
10–12, clones 3T3/6.1A, 3T3/6.1.E, and 3T3/6.3.A
(3T3/Ha-RasV12). 20 g of protein was subjected
to standard Western blot analysis with the anti-
HIP1 monoclonal antibodies, HIP1/4B10 and
HIP1/1B11 (Rao et al., 2002). 50 g of protein
was subjected to Western blot analysis with a
monoclonal Ras antibody, and actin immu-
noblotting was used to demonstrate equal load-
ing of lanes.
B: Quantitation of relative protein levels in HIP1-
overexpressing cells. HIP1 immunoblots were de-
veloped with Pico Plus ECL reagent (Pierce), and
quantitated using a BioRad Fluor S Max camera
(BioRad Corporation). Multiple dilutions of the
samples were used to confirm relative levels of
expression (not shown). Bars 1–9 correspond to
lanes 1–9 in A.
C–E: The growth of 3T3/Ctrl, 3T3/HIP1mod, 3T3/
HIP1hi, and 3T3/Ha-RasV12-expressing cells was
measured by an MTT assay following manufacturer’s instructions (Roche Molecular Biochemicals). Cell lines were grown in 96-well plates in growth media
supplemented with either 10% FBS (C) or 0.1% FBS (D) for 1, 2, 4, and 8 days. , 3T3/Ctrl; , 3T3/HIP1mod; X, 3T3/HIP1hi; and , 3T3/Ha-RasV12). Measurements
were made in quadruplicate for each of the cell lines (see A), and the experiments were repeated twice using the MTT measurements and one additional
time by counting cells with a hemacytometer. E: Relative density of the cell lines after 8 days of growth in either 10% FBS or 0.1% FBS.
cells to growth factors. As expected from their inability to prolif- compared to the 3T3/HIP1hi cells. As in the soft agar assay, the
number of colonies seen with RasV12-overexpressing cell lineserate in 0.1% FBS, 3T3/HIP1mod cells did not have as great an
increase in the proportion of cells in S phase of the cell cycle was lower than that seen with 3T3/HIP1hi cells.
Finally, the ability of these cell lines to form tumors in vivo(Figure 3B).
Since abnormalities in proliferation are a hallmark of cancer- was addressed by subcutaneous injection of HIP1-overexpress-
ing cell lines into nude mice. All 3T3/HIP1hi cell lines formedous cells and HIP1 is overexpressed in tumor cells (Rao et
al., 2002), these data suggested that HIP1 expression may be tumors in nude mice at every injection site (Figures 3E and 4).
Neither the control cell lines nor 3T3/HIP1mod cell lines formeddirectly oncogenic. HIP1-overexpressing cell lines were there-
fore assayed for anchorage-independent growth in soft agar (Di tumors in nude mice during the 16-day course of the experiment.
It is quite possible that 3T3/HIP1mod cell growth in nude mice,Fiore et al., 1987a), ability to form foci when plated at low density
(Sage et al., 2000), and ability to form tumors in nude mice similar to growth in soft agar, lags behind that of 3T3/HIP1hi
cells, and these lines would have eventually formed tumors.(Kokai et al., 1989). By all three counts, HIP1-overexpressing
cells were transformed, while control cell lines were not (Figures Cells expressing RasV12 were used as positive controls in the
nude mouse assays and formed the largest tumors (Figure 4).3C–3E).
Both 3T3/HIP1hi and 3T3/HIP1mod cell lines formed colonies Since these transformation assays all measure different aspects
of tumorigenesis and mutant Ras-transformed cells behavedin soft agar (Figure 3C). 3T3/HIP1mod cells formed fewer colonies,
and colonies of a smaller size, than 3T3/HIP1hi cell lines (Figure differently from the HIP1-transformed cells in several of these
assays, it is likely that HIP1-mediated transformation affects3C, panel 2 versus panel 3). Additionally, the clone with the
lowest level of expression of HIP1, designated 3T3/5.3.E, dis- different aspects of tumorigenesis, depending on its level of
overexpression, and is distinct from RasV12-mediated transfor-played the slowest rate of growth in soft agar (data not shown).
Equivalent numbers of 3T3/HIP1hi cells formed more colonies mation.
The observation of the ability of HIP1-overexpressing cellsin soft agar than mutant Ras-expressing cells. Colonies formed
by mutant Ras-expressing cells tended to be larger on average to grow in the presence of limiting serum suggested to us that
these lines might have increased activation of receptor tyrosinethan colonies formed by HIP1hi cells. In addition, stable cell lines
generated by retroviral infection with MSCVneoHIP1 that uses kinase signaling pathways. This is a well-known mechanism
for transformation which abrogates the requirement for growththe LTR promoter (Figure 1) were also able to form colonies in
soft agar (data not shown). HIP1-overexpressing lines were also factors in the medium in both hematopoietic (Daley and Balti-
more, 1988) and nonhematopoietic cancers (Di Fiore et al.,able to form foci when plated a low density (1.3  103 cells/
100 mm plate), whereas control cell lines were not (Figure 3D). 1987b). Such inappropriate activation of intracellular signaling
can occur either by mutation or simple overexpression of aThe number of foci formed correlated with the level of HIP1
expression, with fewer colonies formed by 3T3/HIP1mod cells receptor tyrosine kinase (Di Fiore et al., 1987a) where elevated
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Figure 3. HIP1 overexpression transforms NIH/3T3 cells
A–B: Cell cycle analysis of 3T3/HIP1 stable lines grown in normal medium (A) and in growth medium supplemented with only 0.1% FBS (B). 106 cells were
plated on 100 mm dishes, grown as described (in 10% or 0.1% FBS for 24 hr), trypsinized, fixed with 70% ethanol, and stained with propidium iodide (Sigma)
to determine DNA content and therefore cell cycle status by flow cytometry.
C: Anchorage-independent growth of 3T3 stable cell lines in soft agar. Cell lines at the same passage number were used for these assays, which have
been previously described (Di Fiore et al., 1987a). Shown are photographs of representative wells for 3T3/Ctrl, 3T3/HIP1mod, 3T3/HIP1hi, and 3T3/Ha-RasV12
cell lines (left panels) to indicate the frequency of colonies formed in soft agar, and photomicrographs (100) of the same wells to show colony size (right
panels) after 16 days in culture. Note that the colony shown in the photomicrograph for 3T3/Ha-RasV12 is larger than the photographic field. The central
dark area is the densest portion of this colony, and the surrounding lighter area shows individual cells that form part of the colony. The light flecks shown
in the photomicrograph for 3T3/Ctrl are individual cells, unable to form the colonies as shown for 3T3/HIP1hi and 3T3/HIP1mod. Three independent experiments
yielded similar results.
D: Proliferation of 3T3 stable lines after plating at low density. 1,300 cells were plated as described (Sage et al., 2000). This experiment was done in duplicate,
and shown are the mean number of colonies and standard deviation for 3T3/Ctrl (n  3 cell lines), 3T3/HIP1mod (n  2 cell lines), 3T3/HIP1hi (n  4 cell lines),
and 3T3/Ha-RasV12 (n  3 cell lines), after 14 days in culture.
E: Growth of 3T3 stable lines in nude mice. 5  105 cells of each cell line were injected subcutaneously into the rear flanks of 6–8 week old Ncr athymic
nude mice (Taconic Farms) and the growth of the tumors was measured every other day. The volume of the tumors was calculated by the formula V 
(L  W2)/2, where L is the length and W is the width of the tumor. For each experimental cell line (3T3/HIP1mod and 3T3/HIP1hi), 3 sites were injected, while
each mouse received a shoulder injection of a positive control (3T3/6.1.E, a RasV12-overexpressing cell line) and a negative control (3T3/4.2.B, a 3T3/Ctrl
cell line). Results are means and standard deviations for each cell line (, 3T3/5.1.E; , 3T3/5.2.D; , 3T3/5.2.C; , 3T3/5.3.F; , 3T3/4.2.B).
levels of growth factor receptors can compensate for lower receptor was not only more highly expressed but also activated
under normal conditions (10% FBS) of growth (Figure 5A, panelsamounts of growth factors in the surrounding tissue fluids. Given
that HIP1 is overexpressed in multiple epithelial cancers and II–V). Flow-cytometric analysis indicated that surface levels of
EGFR were also elevated in 3T3/HIP1hi cell lines (Figure 5B).its overexpression-transformed NIH/3T3 cells, we began our
analysis of the effect of HIP1 overexpression on growth factor The same upregulation of EGFR was not seen in 3T3/HIP1mod
cells (data not shown) or the RasV12-transformed cells.receptors by testing the well-studied EGFR. Remarkably, all
3T3/HIP1hi cell lines showed increased levels of EGFR (Figure Phosphorylation of the EGFR leads to activation of several
intracellular signaling cascades, including the activation of the5A, panel I; lanes 4–7). In addition, Western blot analysis for
phosphorylated forms of the EGFR showed that the EGFR was ERK, PtdIns 3-kinase, and PLC pathways (Figure 6). In 3T3/
HIP1hi cell lines, the entire ERK cascade was found to be acti-phosphorylated at multiple tyrosine residues, indicating that the
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Figure 4. Photographs of nude mice 2 weeks
after subcutaneous injection of HIP1-overex-
pressing cell lines
Injection sites for the various cell lines are listed
below. A: Positive Control (3T3/Ha-RasV12); B:
Negative control (3T3/Ctrl); C: 3T3/5.3.E (3T3/
HIP1mod); D: 3T3/5.2.A (3T3/HIP1mod); E: 3T3/5.1.E
(3T3/HIP1hi); F: 3T3/5.2.D (3T3/HIP1hi); G: 3T3/5.2.C
(3T3/HIP1hi); H: 3T3/5.3.F (3T3/HIP1hi).
vated, with hyperphosphorylation of Raf, MEK-1/2, ERK-1/2, Ha-RasV12 cell lines did have the activation of the MAPK path-
way (Figure 5C; compare lanes 8–10 with lanes 1–3 in all panels),and the downstream target of ERK, p90Rsk (Figure 5C; compare
lanes 4–7 with lanes 1–3 in all panels). Total levels of ERK but not of PtdIns 3-kinase (data not shown).
There was a striking correlation of the expression levels ofand Raf proteins were unchanged. Thus, HIP1 overexpression
contributes to the activation of a well-characterized mitogenic HIP1 with growth characteristics and the results of the transfor-
mation assays (Table 1). Transformation in 3T3/HIP1hi cell linessignaling pathway, via upregulation and activation of EGFR. We
also found that PtdIns 3-kinase, but not PLC, was tyrosine was more robust than that seen in 3T3/HIP1mod, as the latter
did not form tumors in nude mice and formed fewer colonies inphosphorylated in the 3T3/HIP1hi cell lines growing in 10% FBS
(data not shown). In contrast, none of the control cell lines had soft agar. This is very interesting as there is a strong correlation
between HIP1 expression levels and tumor progression in pros-activation of any of these pathways. As expected, 3T3/
Figure 5. HIP1-transformed NIH/3T3 cells have el-
evated EGFR levels
A: Increase in EGFR levels and EGFR tyrosine
phosphorylation in HIP1-overexpressing lines.
Gels were loaded as follows: lanes 1–3, clones
3T3/4.1B, 3T3/4.2.B, and 3T3/4.3.E (3T3/Ctrl); lanes
4–7, clones 3T3/5.1.E, 3T3/5.2.D, 3T3/5.2.C, and
3T3/5.3.F (3T3/HIP1hi); lanes 8–10, clones 3T3/6.1A,
3T3/6.1.E, and 3T3/6.3.A (3T3/Ha-RasV12). Phos-
photyrosine residue-specific antibodies were
used to immunoblot identically loaded gels.
Phospho-Y845 is a potential Src-phosphorylation
site, while the other phosphotyrosine residues are
autophosphorylation sites.
B: Flow cytometric analysis of intact 3T3/Ctrl and
3T3/HIP1hi cells with an extracellular domain-spe-
cific phycoerythrin-conjugated EGFR antibody
shows that 3T3/HIP1hi cells had higher levels of
surface EGFR, as detected by fluorescence in-
tensity. The average fluorescence intensities and
standard deviations for control and 3T3/HIP1hi
cells are shown. Stably transfected cell lines were
grown to 90% confluence and detached from
plates with 0.25% trypsin, and 106 cells were la-
beled with PE-conjugated monoclonal EGFR an-
tibody per manufacturer’s directions (Phar-
mingen, San Diego, CA) and analyzed on a
Beckman-Coulter Elite.
C: Western blot analysis of the Raf-MEK-ERK mito-
genic signaling cascade. Gels were loaded in
the same order as in (A), and Western blot analy-
sis was carried out as described.
D: Proliferation of 3T3 stable lines after plating at
low density in 10% or 0.1% FBS, EGF, and/or the EGFR inhibitor CI-1033. All cells were supplemented with 0.1% FBS or 10% FBS as indicated. E  100 ng/ml
EGF; I  1 M CI-1033. 1,300 cells were plated on 100 cm dishes as described (Sage et al., 2000). This experiment was performed twice with the same
results, showing that the EGFR inhibitor significantly inhibited formation of colonies in 10% FBS (“no E I” compared to “no E”) and that no colonies formed
in the control cells (3T3/Ctrl) grown in 0.1% FBS (“no E”) or HIP1-transformed cells grown in the presence of the EGFR inhibitor (“No E I” or “E I”).
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PtdIns 3-kinase and PLC (Yarden and Sliwkowski, 2001), these
pathways may be required for proliferation under low-serum
conditions. The tyrosine phosphorylation of PI3K in 3T3/HIP1hi
cells may account for this phenomenon. The fact that we could
not detect PLC tyrosine phosphorylation could be due to com-
pensating dephosphorylation in these cells. The data on PtdIns
3-kinase activation, together with the fact that these other path-
ways were not activated by RasV12 expression, predict that the
RasV12-transformed cells would depend on serum for growth
(Table 1 and Figure 5). In addition, the lack of activation of EGFR
in 3T3/HIP1mod cells did not abrogate their ability to grow to
higher densities than control cells or to grow in soft agar. This
indicates that HIP1 overexpression may affect multiple path-
ways that are transforming.
These provocative data led to the question of whether the
HIP1-transformed phenotype was cell intrinsic, or required the
presence of a single growth factor, such as EGF, or a combina-
tion of growth factors in the extracellular milieu. In addition,
since the effect of HIP1 was likely more widespread than just
the EGFR and the transferrin receptor, we wanted to test if
EGFR-mediated signaling was the only pathway that contrib-
uted to the mechanism of HIP1-mediated transformation. To
determine if the transformed phenotype was cell-autonomous,
the soft agar assay was repeated with medium supplemented
with 0.1% FBS rather than the standard of 10% FBS. Under
these conditions, 3T3/HIP1hi cells failed to form anchorage-
independent colonies (data not shown), indicating that supple-Figure 6. Schematic of EGFR-stimulated pathways
mentation with FBS was required for anchorage-independentBinding of EGF to EGFR results in activation of several mitogenic signaling
growth. On the other hand, 3T3/HIP1hi cells do proliferate whenpathways. Our results show activation of the Raf-MEK-ERK signaling cascade
in 3T3/HIP1hi cells and RasV12-overexpressing cells. In addition, the EGFR plated in medium supplemented with 0.1% FBS, albeit at a
and PtdIns 3-kinase are constitutively tyrosine-phosphorylated in the HIP1 much slower rate than in 10% FBS (Figure 2D). This led to the
overexpressing cells but not the RasV12-overexpressing cells. Abbreviations,
hypothesis that these cells were secreting an EGF-like sub-PLC, phospholipase C; PI3K, phosphatidylinositol 3-kinase.
stance or other growth factors into the media that supported
cellular growth in low serum concentrations. In order to test
this, we utilized conditioned medium from 3T3/HIP1hi cells to
supplement the growth medium for 3T3/Ctrl cells (Figure 7B).tate cancer, with higher levels of HIP1 found in more aggressive
This medium failed to stimulate 3T3/Ctrl cells to proliferate attumors (Rao et al., 2002). Thus, it was possible to recapitulate
an increased rate. This result could be due to the fact that 3T3/the growth and survival advantages of high-level HIP1 expres-
Ctrl cells did not have large amounts of EGFR (Figure 5A). Tosion in tumors by direct overexpression of different levels of the
rule out this possibility, we tested the ability of conditionedHIP1 protein in NIH/3T3 fibroblasts.
medium to supplement the growth medium of MCF10A cells,It is also of interest to note that the upregulation of the EGFR
finding that there was little effect on their growth (Figure 7A).in 3T3/HIP1hi cells was associated with both tumor growth in
MCF10A cells are exquisitely sensitive to EGF or other peptidenude mice and growth in limiting serum, while activation of the
hormones with EGF-like activity, and have been used as a stan-ERK pathway in the absence of EGFR activation in RasV12-
dard for testing for EGF-like activity in conditioned mediumexpressing cells correlated with tumor growth in nude mice, but
(Ethier et al., 1991). Since conditioned medium from 3T3/HIP1hinot serum-independent growth (Table 1). Since EGFR is known
to activate pathways other than the ERK cascade, such as cells failed to stimulate growth of MCF10A cells, we concluded
Table 1. Summary of growth and transformation properties of cells used in this study
Growth Transformation assays Signal transduction
10% FBS 0.1% FBS S.A. L.D.P. Nude mouse EGFR ERK cascade PI-3-K
3T3/Ctrl        
3T3/HIP1mod 1       
3T3/HIP1hi 1       
3T3/Ha-RasV12 1       
Abbreviations: FBS, fetal bovine serum; S.A., soft agar assay for anchorage-independent growth; L.D.P, low density plating assay for transformation; PI-3-K,
PtdIns 3-kinase tyrosine phosphorylation.
1 represents growth to higher density than control cells.
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Figure 7. Analysis of requirement of EGF for serum-independent growth and EGFR activation in 3T3/HIP1hi cell lines
A: Secretion of factors with EGF-like activity by 3T3/HIP1hi cells was assayed by growing MCF10A cells in SFIH medium supplemented with tissue culture
supernatant from 3T3/HIP1hi cells. SFIH, serum-free medium supplemented with insulin and hydrocortisone; SFIHE, SFIH medium supplemented with EGF.
Results are mean MCF10A cell number  standard deviation after seven days of growth in the indicated media.
B: Cell growth in conditioned medium from 3T3/HIP1hi cells. Pink: 3T3/HIP1hi cells  1% FBS; light blue: 3T3/HIP1hi cells 3T3/HIP1hi conditioned medium; dark
blue: 3T3/Ctrl  1% FBS; yellow: 3T3/Crl  3T3/HIP1hi conditioned medium.
C: EGF stimulates the growth of 3T3/HIP1hi cells in 0.1% FBS, and EGFR inhibition reduces growth of 3T3/HIP1hi cells in 0.1% FBS plus EGF. All cells were grown
in 0.1% FBS with the daily addition of EGF (100 ng/ml) and/or CI-1033 (1 M). E  EGF. I  EGFR inhibitor. The y axis represents percent of the OD600 at day
1 of the Ctrl cells with nothing added to the 0.1% FBS-containing media.
D: Stimulation of EGFR with EGF and inhibition by CI1033. 3T3/HIP1hi cells were starved in serum-free medium and then stimulated with either EGF at 100
ng/ml with or without pretreatment for 1 hr with 1 M CI1033 as indicated. 50 g of protein were analyzed by Western blot for phosphorylated EGFR and
total EGFR as indicated.
E: EGF stimulation of 3T3/Ctrl and 3T3/HIP1hi cells. 50 g of protein were analyzed with antibodies to phosphorylated and total EGFR.
F: Upregulation of other tyrosine kinase receptors in 3T3/HIP1hi cells. 50 g of protein extracts from the stably transfected cell lines were analyzed by Western
blot for FGFR-3 and FGFR-4 as indicated.
that there was not significant EGF-like activity secreted by the tion by EGF-like compounds. Following starvation of serum, we
found that the EGFR in 3T3/HIP1hi cells was quiescent, andtransformed cells into the conditioned medium. Thus, the condi-
tioned medium from the HIP1-transformed cells did not contain its activation (tyrosine phosphorylation) was very sensitive to
stimulation by EGF (Figures 7D and 7E). This stimulation wasgrowth factors that could stimulate either NIH/3T3 cells or
MCF10A cells to grow. completely inhibited by the EGFR inhibitor, CI-1033 (Figure 7D)
(Slichenmyer and Fry, 2001). When 3T3/HIP1hi cells were grownSince there was no added activity in the conditioned medium
from the HIP1-transformed cells, and since the cells required in medium containing the EGFR inhibitor CI-1033, there was
inhibition of EGF-stimulated growth in 0.1% FBS (Figure 7C)FBS to grow in soft agar, we next tested if EGFR activation in
3T3/HIP1hi cells was constitutive, or whether it required stimula- and inhibition of their ability to form foci when plated at low
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density in 10% or 0.1% FBS. When CI-1033 was added, ability that EGF accumulation in the cell was dramatically increased
of HIP1hi cells to form colonies in 0.1% FBS was completely in the 3T3/HIP1hi cells (Figure 8D). We also found that accumula-
inhibited, while the ability to form colonies in 10% FBS was tion of transferrin was increased in HIP1-overexpressing cells
significantly inhibited with decreases in colony number as well compared to 3T3/Ctrl cells. This accumulation was assessed
as colony size (Figure 5D). Addition of EGF to HIP1hi cells plated both by confocal microscopy (Figure 8E) and flow-cytometry
in 0.1% FBS caused an increase in the number of colonies (Figure 8F). The absence of such an effect on transferrin accu-
formed, and this effect was abrogated by the addition of CI- mulation in vector-transfected cells demonstrated that this ef-
1033 (Figure 5D). As expected, when plated at low density, 3T3/ fect was specific to HIP1 overexpression. As one might expect,
Ctrl cells that were not expressing HIP1 did not form significant 3T3/HIP1mod cell lines had intermediate levels of transferrin and
numbers of colonies in 10% FBS and 0.1% FBS. These data EGF uptake (data not shown). Hence, HIP1 led to increased
demonstrated that EGF/EGFR were required for some aspects levels of receptors in the HIP1-transformed cells, and this led
of the transformed phenotype. However, the lack of a large to increased ligand accumulation and activation of receptors.
effect of the inhibitor on growth per se (Figure 7C) indicated Since EGFR is often overexpressed in breast cancer and
that other aspects of the transformed phenotype occurred as EGFR was upregulated in the HIP1-transformed cells, we sought
a result of more widespread effects of HIP1. to obtain a concomitant analysis of HIP1 and EGFR expression
To begin to test what these additional effects might be, we in a series of primary human breast tumors. Using immunohisto-
assessed the levels of expression of other candidate growth chemistry and tissue microarrays (TMAs), a comprehensive
factor receptors in the HIP1-transformed cells compared to the analysis of HIP1 and EGFR expression was achieved in breast
control cells. We found that FGFR-3 and FGFR-4 were consis- cancer. 183 specimens from 40 patients with breast cancer were
tently upregulated in 3T3/HIP1hi cells (Figure 7F). Thus, the represented on a TMA that included sections corresponding to
growth of the HIP1-transformed cells in low serum or at conflu- normal breast, fibrocystic changes, atypical ductal hyperplasia
ence was not solely dependent on EGFR activity and may be (ADH), ductal carcinoma in situ (DCIS), and invasive breast can-
the result of upregulation of other tyrosine kinase receptors as cer. The array was first analyzed for HIP1 expression by immu-
well. In contrast, the focus formation assay that is a bona fide nohistochemical staining. Normal breast tissue mostly exhibited
measure of transformation was dependent on active EGF signal- low or no HIP1 expression (Figure 9A), as did breast tissue with
ing pathways. fibrocystic changes (data not shown). ADH and DCIS, which
Because a major abnormality in these cells was the in- are noninvasive lesions thought to be precursors of invasive
creased level of multiple growth factor receptors, we began to
breast cancer, had mostly moderate and high levels of HIP1
investigate how HIP1 might cause the upregulation of these
expression (Figures 9B–9D). Invasive carcinomas also tended
receptors. Since HIP1 physically interacts with clathrin and the
to have moderate and high levels of HIP1 expression (Figuresendocytic adaptor protein, AP2, the effect of HIP1 on the levels
9E and 9G), although a minority of carcinomas did not have anyand localization of these proteins was examined. In 3T3/HIP1hi
HIP1 expression (Figure 9F). These differences in HIP1 expres-cells, there was no change in the overall levels of clathrin heavy
sion between normal and neoplastic tissue in this group ofchain, but AP2 levels were diminished (Figure 8A). In addition,
patients were highly significant (Figure 9H; Pearson’s chi-the subcellular localization of clathrin and AP2 in 3T3/HIP1hi
squared, p	 0.001). Additionally, comparison of tissue samplescells and the 3T3/Ctrl cells were assessed. In the 3T3/HIP1hi
within each patient showed higher levels of HIP1 expression incells, location of the remaining AP2 was not altered compared
cancerous as opposed to normal tissue (paired sample t test,to the control cells (data not shown). In contrast, clathrin was
p 	 0.001; Supplemental Figure S1 at http://www.cancercell.concentrated in the perinuclear area, with less clathrin present
org/cgi/content/full/3/5/471/DC1). Thus, elevated expression ofat the cell periphery compared to the 3T3/Ctrl cells (Figure 8B).
HIP1 marked neoplastic tissue within clinical specimens thatCoimmunofluorescent labeling with a Golgi marker and clathrin
contained both normal and cancerous tissues. The elevatedconfirmed that clathrin was concentrated in the area of the
levels of HIP1 in cancerous tissue led us to stain the same TMAtrans-Golgi network (Figure 8C). This Golgi localization suggests
for EGFR to determine if, in vivo, HIP1 expression led to thethat in these HIP1-transformed cells, clathrin is less available to
same elevation of the EGFR seen in 3T3-HIP1hi cell lines. Inparticipate in endocytosis at the cell membrane. The decreased
fact, we found that tumors that did not express HIP1 did notlevels of AP2 may explain this altered localization, as AP2 nor-
express EGFR (Figure 9I), while tumors that overexpressed HIP1mally recruits clathrin to the plasma membrane. This mislocal-
also overexpressed EGFR (Figure 9J).ization of clathrin could cause an attenuation of normal endocy-
Consistent with the elevated expression of HIP1 seen intosis and decrease the steady state degradation of growth factor
primary tumors, we have also found that all the breast cancerreceptors, in turn leading to an increase in the overall level of
cell lines we have tested expressed high levels of HIP1 (Rao etreceptor tyrosine kinases. This also explains why the HIP1-
al., 2002). Since HIP1 overexpression led to oncogenic transfor-transformed cells have increased sensitivity to growth factor
mation, we tested the ability of a dominant interfering mutant,stimulation.
HIP1/E, to induce apoptosis in the HIP1-expressing breastThe alteration of trafficking in these cells was also examined
cancer cell line BT549. Indeed, overexpression of the HIP1/Eby immunofluorescent and flow cytometric assays to assess
led to apoptosis in this cell line as assayed by TUNEL (Supple-EGF and transferrin accumulation in cells. Prior studies have
mental Figure S2 at http://www.cancercell.org/cgi/content/full/shown that expression of HIP1 mutants lacking the ENTH and
3/5/471/DC1). This analysis, together with the cumulative datacoiled-coil domains are potent inhibitors of endocytosis of trans-
on HIP1 overexpression in primary tumors and HIP1’s ability toferrin, while the full-length protein promoted efficient uptake
confer transformation properties on NIH 3T3 cells, suggests(Metzler et al., 2001). First, the effect of HIP1 overexpression
on EGF trafficking was examined. This analysis demonstrated that HIP1 is a novel therapeutic target.
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Figure 8. Alterations in endocytosis in HIP1-overexpressing cells
A: Western blot analysis of levels of endocytic HIP1 interactors in stable cell lines used in this study. CHC, clathrin heavy chain; 
-adaptin is the 110 kDa
subunit of the AP2 adaptor protein complex.
B: Confocal immunofluorescent analysis of HIP1 and clathrin heavy chain (CHC) in 3T3/Ctrl and 3T3/HIP1hi cells. Cells were coimmunostained for CHC
(green) and HIP1 (red).
C: Confocal immunofluorescent analysis of CHC (green) and the Golgi marker, GM130 (red). The merged images are shown to demarcate areas of
colocalization (yellow).
D: Stably transfected cells were plated on coverslips, serum-starved, incubated for 60 min at 4C with FITC-EGF (molecular probes), and then shifted to
37C for 30 min, fixed, and mounted onto slides. Images were taken on Zeiss LSM confocal microscope. The 3T3/Ctrl and 3T3/HIP1hi cell lines were analyzed
for uptake at the same time and the camera’s exposure time for visualization of the uptake was identical. The photos are representative of what was
visualized for the 3T3/HIP1hi (upper panels) and the control lines (lower panels).
E: Images of cell lines following AlexaFluor 633-transferrin uptake. The camera’s exposure time for visualization of the uptake was identical as described
in D.
F: AlexaFluor 633-conjugated transferrin accumulation in NIH 3T3 stable lines as quantitated by flow cytometry. The cell lines tested in this assay were vector
control (3T3/Ctrl) lines (3T3/4.1.B, 4.2.B, 4.3.E) and high-HIP1 expressing lines (3T3/5.1.E, 5.2.C, 5.2.D, and 5.3.F). To allow for binding of transferrin to the
transferrin receptor, all the samples were kept at 4C for 1 hr after addition of AlexaFluor 633-transferrin. Cells were then transferred to 37C and aliquots
were analyzed by flow cytometry at various time points. Each time point was done in triplicate and the averages are presented. Three independent
experiments were performed on all cell lines.
Discussion pression of Eps15 in NIH/3T3 fibroblasts causes anchorage-
independent growth, similar to what is reported here for HIP1
(Fazioli et al., 1993). A second endocytic protein, intersectin,Our data, which indicate a fairly global effect on endocytosis
in 3T3/HIP1hi cell lines, including changes in AP2 levels, a redis- has also been shown to cause anchorage-independent growth
in NIH/3T3 fibroblasts when overexpressed (Adams et al., 2000).tribution of clathrin, and elevated levels of multiple cell surface
receptors, suggest that HIP1’s rate-limiting role in clathrin-medi- Whether the Eps15 and intersectin proteins are elevated in pri-
mary human cancers, cause cells to form tumors in vivo, orated trafficking is the mechanism of transformation. Additional
evidence for a role of endocytic proteins in cellular transforma- cause cells to grow in the presence of limiting serum concentra-
tions remains to be determined.tion comes from studies of Eps15, a protein that colocalizes
with clathrin-coated vesicles (Confalonieri et al., 2000). Overex- As mentioned above, the mechanism of HIP1-mediated
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Figure 9. HIP1 and EGFR expression in primary hu-
man breast tissues
Slides were stained with monoclonal anti-HIP1
antibody 4B10 or the EGFR antibody (Zymed Lab-
oratories Inc). Slides were reviewed in their en-
tirety during three independent reading sessions
by a pathologist (C.G.K.), an oncologist (T.S.R.),
and two of the other authors (D.S.R., T.S.H.). There
was greater than 95% concordance of score as-
signments between the three independent
reading sessions. A–G: Low-power photomicro-
graphs of representative specimens: normal
breast epithelium (A); ADH with HIP1 staining in
myoepithelial cells (B); papillary hyperplasia with
HIP1 staining of the endothelium in the fibrovas-
cular core (C); HIP1 staining of DCIS with comedo
necrosis (*) (D); HIP1 staining of invasive lobular
carcinoma with typical single filing of tumor cells
(E); invasive ductal carcinoma with no HIP1 stain-
ing (F); and invasive ductal carcinoma with high
HIP1 staining (G).
H: Histogram of immunohistochemical score dis-
tribution (HIP1 staining) from analysis of breast
tissue samples. 183 specimens from 40 patients
were analyzed. Samples were grouped into
three categories (normal, in situ, invasive). The
normal category included samples diagnosed
as normal and fibrocystic changes, the in situ
category consisted of atypical ductal hyperpla-
sia and DCIS, and the invasive category con-
sisted of both invasive lobular and ductal carci-
noma.
I: EGFR staining is negative in HIP1-negative pri-
mary breast tumors.
J: HIP1 is overexpressed in EGFR-positive tumors.
transformation of NIH/3T3 cells likely involves a profound dys- the EGFR. The increase in surface levels of growth factor recep-
tors would be expected to lead to the observed increased sensi-regulation of trafficking of multiple growth factor receptors. Pre-
vious published results suggest that HIP1 promotes endocytic tivity of the cells to growth factors. We speculate that EGFR
upregulation may be a major contributing mechanism towarduptake of cell surface receptors (Metzler et al., 2001). With the
latter observations, it may not be obvious why endocytosed transformation. The main reason for this is that the overexpres-
sion of EGFR has been shown previously to be a transformingreceptors became upregulated rather than downregulated in
the HIP1-transformed cells. One possibility is that HIP1 is rate- event in NIH/3T3 cells in an EGF-dependent manner (Di Fiore
et al., 1987a), and the transformed phenotype in our case re-limiting to the process of endocytosis but also inhibits lysosomal
targeting and degradation of the receptors, leading to increased quired the presence of extrinsic growth factors. However, the
initial event of receptor tyrosine kinase overexpression and in-recycling of these receptors to the cell surface. Overexpression
of another Huntingtin associated protein, HAP1, has also re- creased activation by the overexpression of HIP1 may have
then allowed further mutations to accumulate, leading to thecently been shown to inhibit the degradation of EGFR (Li et al.,
2002). Alternatively, HIP1, by virtue of its ability to bind to AP2, phenotype of growth in lowered serum that was independent
of EGF stimulation (Figure 7C). The phenomenon of an initialmay lead to AP2 downregulation posttranscriptionally. This in
turn could cause clathrin to be redistributed to the trans-Golgi oncogenic stimulus being no longer required for the perpetua-
tion of some aspects of the transformed phenotype was recentlynetwork (as AP2 is required for recruitment of clathrin to the
cell surface), where it is less available for endocytosis. This described elegantly in a mouse model system (Moody et al.,
2002). Alternatively, the dysregulation of trafficking of multiplewould then lead to cell surface receptor upregulation and, be-
cause of the increased receptor density, increased endocytosis GFRs may explain the partial dependence on the EGFR for
transformation.upon ligand stimulation. In addition to these proposed mecha-
nisms for HIP1-mediated upregulation of cell surface receptors, In sum, the ability of HIP1 to transform cells is consistent
with its overexpression in breast, colon, and prostate cancerthere is data to suggest that full intracellular signaling originating
from receptor tyrosine kinases requires the ligand-mediated as well as multiple other cancers (Rao et al., 2002). It is also
consistent with the idea that HIP1 expression is necessary forendocytosis of these receptors (Vieira et al., 1996). Since uptake
of EGF was increased in HIP1-transformed cells, this may con- the survival of some cells (Rao et al., 2002). This report directly
links the altered expression in epithelial cancers of a proteintribute to the increased levels of mitogenic signaling observed
in these cells. involved in clathrin trafficking with known pathways of cellular
transformation. It does this by showing that HIP1-mediatedThis dysregulation of endocytosis caused a change in the
steady-state levels of multiple cell surface receptors, including transformation results from altered clathrin trafficking that leads
480 CANCER CELL : MAY 2003
A R T I C L E
Immunofluorescent labeling and confocal microscopyto elevated levels and activation of receptor tyrosine kinases.
For immunofluorescent labeling of cells, the polyclonal HIP1 antibody, pc-HIP1 could therefore be both an important tumor marker and
HIP1, the monoclonal anti-clathrin antibody, X22 (kind gift of Dr. Linton Traub,a novel target for therapy. By linking the basic biological process
University of Pittsburgh), and the Golgi marker, GM130 (Signal Transduction
of trafficking and mitogenic intracellular signaling with oncogen- Labs) were utilized as previously described (Rao et al., 2001, 2002). Images
esis, a new insight has been gained into the mechanisms were acquired under Zeiss LSM 510 confocal microscope as previously
whereby normal cells become cancerous. described, and images were processed utilizing Adobe Photoshop.
Analysis of EGF and transferrin traffickingExperimental procedures
For immunofluorescent analysis of transferrin and EGF uptake, stably trans-
fected cells were plated on coverslips so that they were about 70% confluentGeneration of cell lines overexpressing HIP1
the day of the experiment. Cells were then serum-starved for 3 hr prior toThe construction of the full-length HIP1 construct, pcDNA3/FLHIP1, has
addition of the labeled transferrin or 16 hr prior to addition of EGF. AlexaFluorbeen described (Rao et al., 2002). The insert, containing the entire HIP1
633-transferrin or FITC-EGF (Molecular Probes) was added to the cells atcoding sequence as well as 60 base pairs of 5 untranslated DNA in exon
50 g/ml in DMEM, and incubated at 4C for 60 min. The cells were then1, was subcloned into pTRE2-Hyg (Clontech). Ha-RasV12 was excised with
incubated at 37C for 30 min, fixed in 3% formaldehyde, washed with PBS,BamHI (5) and EcoRI (3) from pBabepuro/Ha-RasV12 (kind gift of Dr. Maria
and mounted onto slides with Vectashield. Images (fluorescent and Nomar-Soengas, Cold Spring Harbor Laboratories) and subcloned into the BamH1/
sky) were taken on Zeiss LSM confocal microscope.EcoRI-digested pcDNA3 to create pcDNA3/Ha-RasV12. NIH/3T3 (ATCC,
For analysis of Alexa Fluor 633-transferrin accumulation by flow cytome-Manassas, VA) cells were transfected with pTRE2-Hyg or pTRE2-Hyg/HIP1
try, confluent cells were serum-starved for 3 hr, after which they were trypsin-and selected in 200 g/ml Hygromycin B (Clontech), or pcDNA3/Ha-
ized. They were then washed in cold PBS/1%BSA twice and resuspendedRasG12V, and selected in 400 g/ml G418 (Invitrogen). Individual clones
in DMEM. Alexa Fluor 633-Transferrin (Molecular Probes) was added (50were picked after 2 weeks of selection, and cell lines were passaged every
g/ml) to the cells on ice. The cells were then maintained, rotating in thefour days. All clones from transfections with HIP1 and RasV12 demonstrated
dark at 4C for 1 hr. To test for uptake, the cells were shifted to 37C andexpression of HIP1 and Ras respectively. All experiments were performed
maintained in the dark, rotating. At each timepoint, cells were washed inwith cell lines at the same passage number.
PBS at 4C and resuspended in 1% paraformaldehyde in PBS. The samples
were then analyzed for fluorescence by flow cytometry.Western blot analyses
Cells were harvested at confluence and lysed in Lysis Buffer A10, supple-
Preparation of and use of conditioned media from 3T3/HIP1himented with protease/phosphatase inhibitors (Roche), run on 7% or 10%
cell linesSDS-PAGE transferred to nitrocellulose, and immunoblotted with the follow-
3T3/HIP1hi cell lines were grown in medium supplemented with 1% FBS foring antibodies: HIP1/4B10, which recognizes human HIP1 only, and HIP1/
48 hr, and the tissue culture supernatant was collected after cellular debris1B11, which recognizes both mouse and human HIP1. The anti-clathrin
was removed by centrifugation. This medium was then used to supplementmonoclonal antibody, Td.1, was the kind gift of Linton Traub, University of
SFIH medium in a 1:1 ratio, in order to grow MCF10A cells (which are EGF-Pittsburgh. Other antibodies were commercially available. (Anti-
-adaptin
dependent). Briefly, 3.5  104 MCF10A cells were plated in triplicate in six-monoclonal antibody, Sigma Chemical Company, St. Louis, MO; Ras mono-
well dishes, and grown in medium for 7 days as described (Ethier et al.,clonal antibody, Transduction Labs, San Diego, CA; phospho ERK 1/2,
1991). Medium was replaced every two days. Cell numbers were quantitatedFGFR-3, and FGFR-4, Santa Cruz Biotechnology, Santa Cruz, CA; all other
with a coulter counter. Cells grown in SFIH medium supplemented with EGF
antibodies were obtained from Cell Signaling Technologies, Beverly, MA).
(SFIHE) were the positive control.
3T3/Ctrl and 3T3/HIP1hi cells were grown in medium supplemented
Low-density focus formation in limiting serum
with conditioned medium from the 3T3/HIP1hi cells to determine if secreted
For plating at low density in limiting serum, the method of Sage et al. (2000) factor(s) was responsible for the increased growth properties of 3T3/HIP1hi
was modified as follows. Cells were briefly trypsinized and resuspended in cells. Cell lines were plated in 96 well plates at a concentration of 5  104
DMEM supplemented with 0.1% FBS. 1,300 cells were immediately plated cell/ml in 100 l per well of DMEM media supplemented with 1% FBS. 100
in the same medium. The next day, the medium was changed to include l of conditioned media from 3T3/HIP1hi cell lines was added 24 hr later,
either EGF (100 ng/ml) and/or the erbB inhibitor, CI-1033 (1M). The medium and the negative control cells received 100 l of medium supplemented
was changed every third day. At day 10, the plates were examined for the with 1% FBS. MTT reagents were added at days 1, 2, 5, and 10, according
presence of colonies visible to the naked eye and quantitated. to manufacturer’s protocol (Roche), and the plate was read at a wavelength
of 600 nm. Results from cells treated with medium supplemented with 1%
Analysis of HIP1 and EGFR expression in primary breast tumors FBS are an average of 12 wells per day with 3 cell lines represented. Results
TMAs were created as previously described (Kononen et al., 1998; Perrone from cells treated with conditioned media are an average of 36 wells per
et al., 2000). Cases of breast cancer were collected from sequential patients day with 3 cell lines and 3 types of conditioned media represented.
seen at the University of Michigan breast care center. Staining for HIP1 was
as described (Rao et al., 2002). Initial sections were stained for H and E to EGFR inhibitor effect on the MTT assay
verify histological diagnoses. Statistical analysis was completed using the Cell lines were plated in 96-well plates at a concentration of 5  104 cell/
SPSS program as previously described (Rao et al., 2002). ml in DMEM media with 0.1% FBS. EGF inhibitor CI1033 (1 M) and /or
EGF (100 ng/ml) was added daily, starting 24 hr after plating the cells. MTT
Apoptosis assay reagents were added at days 1, 2, 3, and 4, according to manufacturer’s
Apoptosis was determined by transfecting the BT549 human breast cancer protocol (Roche), and the plate was read at a wavelength of 600 nm. Results
cell line with full-length HIP1 and HIP1/E. After allowing for expression of are an average of 12 wells per day with 3 cell lines represented.
the protein (15 hr), cells were fixed in PBS with 5% paraformaldehyde for
1 hr and permeabilized with 0.1% Triton X-100. Cells were then labeled with EGF stimulation of cell lines
fluorescein-tagged dUTP using the InSitu Cell Death Kit (Roche Molecular 3T3/HIP1hi cells were plated in 6-well plates or 150 mm dishes. 24 hr later,
Biochemicals), following manufacturer’s instructions. Following TUNEL la- cells were starved in serum-free media. After 4 hr of serum starvation, cells
beling, cells were labeled with HIP1/4B10, followed by Texas Red-tagged were incubated for 1 hr with CI-1033 and then treated with 100 ng/ml EGF
secondary antibody. Labeling was visualized by confocal microscopy (Carl for 5 min and lysed. 50 g of protein from each lysate was analyzed by
Zeiss MicroImaging Inc., Thornwood, New York) as previously described Western blot. Membranes were immunoblotted with either polyclonal anti-
(Rao et al., 2001). The proportion of transfected cells (labeled red) that were phospho-EGFR (Tyr845) antibody or polyclonal anti-EGFR antibody (both
from Cell Signaling, Inc.).also TUNEL-positive (green) was counted.
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